Mivelsiran: Clinical Trials

2 trials of Mivelsiran, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Recruiting 1

Follow Mivelsiran: new trials by email Literature Review of Mivelsiran trials Research Report on Mivelsiran

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Mivelsiran, Placebo - Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Phase 2RecruitingAlnylam Pharmaceuticals582026-08-172026-11-18
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
Placebo, ALN-APP - Cerebral Amyloid Angiopathy
Phase 2Active not recruitingAlnylam Pharmaceuticals2102024-05-172026-11-13

Conditions studied

Cerebral Amyloid Angiopathy (1)  ·  Down Syndrome (1)

Sponsors

Alnylam Pharmaceuticals (2)

Countries

United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Switzerland (1)

NIH funding

2023 (1)